China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the efficacy of Loteprednol Etabonate Ophthalmic Suspension in improving follicular development in patients with premature ovarian insufficiency'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130235
Registration Time: 2026/08/17
Type: Interventional study
Primary Sponsor: The University of Hongkong - Shenzhen Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336168
Published by HT Digital Content Services with permission from Health Daily Digest....